| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.24 | 0.06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |